|
1
|
Kular J, Tickner J, Chim SM and Xu J: An
overview of the regulation of bone remodelling at the cellular
level. Clin Biochem. 45:863–873. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chim SM, Tickner J, Chow ST, Kuek V, Guo
B, Zhang G, Rosen V, Erber W and Xu J: Angiogenic factors in bone
local environment. Cytokine Growth Factor Rev. 24:297–310. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boyce BF and Xing L: Functions of
RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem
Biophys. 473:139–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kwan Tat S, Padrines M, Théoleyre S,
Heymann D and Fortun Y: IL-6, RANKL, TNF-alpha/IL-1: Interrelations
in bone resorption pathophysiology. Cytokine Growth Factor Rev.
15:49–60. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zou W, Hakim I, Tschoep K, Endres S and
Bar-Shavit Z: Tumor necrosis factor-α mediates RANK ligand
stimulation of osteoclast differentiation by an autocrine
mechanism. J Cell Biochem. 83:70–83. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gilbert L, He X, Farmer P, Boden S,
Kozlowski M, Rubin J and Nanes MS: Inhibition of osteoblast
differentiation by tumor necrosis factor-α. Endocrinology.
141:3956–3964. 2000.PubMed/NCBI
|
|
7
|
Puimège L, Libert C and Van Hauwermeiren
F: Regulation and dysregulation of tumor necrosis factor
receptor-1. Cytokine Growth Factor Rev. 25:285–300. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kozawa O, Suzuki A, Kaida T, Tokuda H and
Uematsu T: Tumor necrosis factor-alpha autoregulates interleukin-6
synthesis via activation of protein kinase C. Function of
sphingosine 1-phosphate and phosphatidylcholine-specific
phospholipase C. J Biol Chem. 272:25099–25104. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Minamitani C, Tokuda H, Adachi S,
Matsushima-Nishiwaki R, Yamauchi J, Kato K, Natsume H, Mizutani J,
Kozawa O and Otsuka T: p70 S6 kinase limits tumor necrosis
factor-α-induced interleukin-6 synthesis in osteoblast-like cells.
Mol Cell Endocrinol. 315:195–200. 2010. View Article : Google Scholar
|
|
10
|
Hirano T, Yasukawa K, Harada H, Taga T,
Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K,
Iwamatsu A, et al: Complementary DNA for a novel human interleukin
(BSF-2) that induces B lymphocytes to produce immunoglobulin.
Nature. 324:73–76. 1986. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Johnson RW, Brennan HJ, Vrahnas C, Poulton
IJ, McGregor NE, Standal T, Walker EC, Koh TT, Nguyen H, Walsh NC,
et al: The primary function of gp130 signaling in osteoblasts is to
maintain bone formation and strength, rather than promote
osteoclast formation. J Bone Miner Res. 29:1492–1505. 2014.
View Article : Google Scholar
|
|
12
|
Fazzalari NL: Bone fracture and bone
fracture repair. Osteoporos Int. 22:2003–2006. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Franchimont N, Wertz S and Malaise M:
Interleukin-6: An osteotropic factor influencing bone formation?
Bone. 37:601–606. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Holst JJ: The physiology of glucagon-like
peptide 1. Physiol Rev. 87:1409–1439. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Meier C, Schwartz AV, Egger A and
Lecka-Czernik B: Effects of diabetes drugs on the skeleton. Bone.
82:93–100. 2016. View Article : Google Scholar
|
|
16
|
Baggio LL and Drucker DJ: Biology of
incretins: GLP-1 and GIP. Gastroenterology. 132:2131–2157. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bollag RJ, Zhong Q, Phillips P, Min L,
Zhong L, Cameron R, Mulloy AL, Rasmussen H, Qin F, Ding KH, et al:
Osteoblast-derived cells express functional glucose-dependent
insulinotropic peptide receptors. Endocrinology. 141:1228–1235.
2000.PubMed/NCBI
|
|
18
|
Bollag RJ, Zhong Q, Ding KH, Phillips P,
Zhong L, Qin F, Cranford J, Mulloy AL, Cameron R and Isales CM:
Glucose- dependent insulinotropic peptide is an integrative hormone
with osteotropic effects. Mol Cell Endocrinol. 177:35–41. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamada C, Yamada Y, Tsukiyama K, Yamada K,
Udagawa N, Takahashi N, Tanaka K, Drucker DJ, Seino Y and Inagaki
N: The murine glucagon-like peptide-1 receptor is essential for
control of bone resorption. Endocrinology. 149:574–579. 2008.
View Article : Google Scholar
|
|
20
|
Sanz C, Vázquez P, Blázquez C, Barrio PA,
Alvarez MM and Blázquez E: Signaling and biological effects of
glucagon-like peptide 1 on the differentiation of mesenchymal stem
cells from human bone marrow. Am J Physiol Endocrinol Metab.
298:E634–E643. 2010. View Article : Google Scholar
|
|
21
|
Sudo H, Kodama HA, Amagai Y, Yamamoto S
and Kasai S: In vitro differentiation and calcification in a new
clonal osteogenic cell line derived from newborn mouse calvaria. J
Cell Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kozawa O, Tokuda H, Miwa M, Kotoyori J and
Oiso Y: Cross-talk regulation between cyclic AMP production and
phosphoinositide hydrolysis induced by prostaglandin E2
in osteoblast-like cells. Exp Cell Res. 198:130–134. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Simpson DA, Feeney S, Boyle C and Stitt
AW: Retinal VEGF mRNA measured by SYBR green I fluorescence: A
versatile approach to quantitative PCR. Mol Vis. 6:178–183.
2000.PubMed/NCBI
|
|
24
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kato K, Ito H, Hasegawa K, Inaguma Y,
Kozawa O and Asano T: Modulation of the stress-induced synthesis of
hsp27 and α B-crystallin by cyclic AMP in C6 rat glioma cells. J
Neurochem. 66:946–950. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hehlgans T and Pfeffer K: The intriguing
biology of the tumour necrosis factor/tumour necrosis factor
receptor superfamily: Players, rules and the games. Immunology.
115:1–20. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kobori M, Yang Z, Gong D, Heissmeyer V,
Zhu H, Jung YK, Gakidis MA, Rao A, Sekine T, Ikegami F, et al:
Wedelolactone suppresses LPS-induced caspase-11 expression by
directly inhibiting the IKK complex. Cell Death Differ. 11:123–130.
2004. View Article : Google Scholar
|
|
28
|
Yu Z and Jin T: New insights into the role
of cAMP in the production and function of the incretin hormone
glucagon-like peptide-1 (GLP-1). Cell Signal. 22:1–8. 2010.
View Article : Google Scholar
|
|
29
|
Chijiwa T, Mishima A, Hagiwara M, Sano M,
Hayashi K, Inoue T, Naito K, Toshioka T and Hidaka H: Inhibition of
forskolin-induced neurite outgrowth and protein phosphorylation by
a newly synthesized selective inhibitor of cyclic AMP-dependent
protein kinase, N-[2-(p-bromocinnamylamino)
ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma
cells. J Biol Chem. 265:5267–5272. 1990.PubMed/NCBI
|
|
30
|
Nuche-Berenguer B, Portal-Núñez S, Moreno
P, González N, Acitores A, López-Herradón A, Esbrit P, Valverde I
and Villanueva-Peñacarrillo ML: Presence of a functional receptor
for GLP-1 in osteoblastic cells, independent of the cAMP-linked
GLP-1 receptor. J Cell Physiol. 225:585–592. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Seino Y and Yabe D: Glucose-dependent
insulinotropic polypeptide and glucagon-like peptide-1: Incretin
actions beyond the pancreas. J Diabetes Investig. 4:108–130. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hoffmann A and Baltimore D: Circuitry of
nuclear factor-κB signaling. Immunol Rev. 210:171–186. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Karsenty G and Wagner EF: Reaching a
genetic and molecular understanding of skeletal development. Dev
Cell. 2:389–406. 2002. View Article : Google Scholar : PubMed/NCBI
|
